[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sol-Gel Technologies Ltd (SLGL)

Sol-Gel Technologies Ltd (SLGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sol-Gel Technologies Ltd 7 GOLDA MEIR ST WEIZMANN SCIENCE PARK NESS ZIONA L3 7403648 ISR

www.sol-gel.com Employees: 28 P: 972-8931-3429 F: 352-304-4444

Sector:

Medical

Description:

Sol-Gel Technologies Ltd.is a clinical-stage dermatology company. It focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Its product candidates include VERED for the treatment of papulopustular rosacea, TWIN and SIRS-T for the treatment of acne vulgaris, which are in its clinical stage. Sol-Gel Technologies Ltd.is based in Israel.

Key Statistics

Overview:

Market Capitalization, $K 207,961
Enterprise Value, $K 196,931
Shares Outstanding, K 2,810
Float, K 941
% Float 33.49%
Short Interest, K 52
Short Float 1.87%
Days to Cover 1.38
Short Volume Ratio 0.72
% of Insider Shareholders 66.51%
% of Institutional Shareholders 26.18%

Financials:

Annual Sales, $ 19,390 K
Annual Net Income, $ -6,130 K
Last Quarter Sales, $ 110 K
Last Quarter Net Income, $ -3,730 K
EBIT, $ -2,390 K
EBITDA, $ -2,280 K

Growth:

1-Year Return 891.43%
3-Year Return 137.21%
5-Year Return -39.83%
5-Year Revenue Growth 121.09%
5-Year Earnings Growth 83.15%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.31 on 05/28/26
Next Earnings Date 08/21/26
Earnings Per Share ttm -0.34
EPS Growth vs. Prev Qtr -22.43%
EPS Growth vs. Prev Year 59.06%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 05/05/25

SLGL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -3.17%
Return-on-Assets % -2.58%
Profit Margin % -31.61%
Debt/Equity 0.00
Price/Sales 10.43
Price/Cash Flow N/A
Price/Book 4.05
Book Value/Share 18.30
Interest Coverage -0.49
60-Month Beta 1.12
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.